Recruiting

Observational Study

Sponsor:

Dana-Farber Cancer Institute

Code:

NCT04630496

Conditions

Thoracic Diseases

Surgery

Therapy, Exercise

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

Fitbit

Study Details

Brief summary:

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery.

The name(s) of the study device involved in this study is:

  • Fitbit inspire

Conditions

Thoracic Diseases

Surgery

Therapy, Exercise

Study ID

NCT04630496

Start date

Aug 25, 2021

Status verified date

Apr, 2025

Completion date

Jan 1, 2026

Anticipated

Primary completion date

Dec 1, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients Aged ≥ 65 years

  • Who are preparing to undergo thoracic surgery at Brigham and Women's Hospital (BWH)

Exclusion Criteria:

  • Patients who are completely non-ambulatory (i.e. wheelchair-bound-patients) \*
  • Those who lack capacity to consent due to cognitive disease.
  • Patient for which surgery is felt to be more urgent and therefore performed earlier then our required timeframe for intervention.
  • Patients with cardiac disease or angina for which formal cardiac testing is required for clearance.

  • Our exclusion criteria do not include patients with gait disturbances or those who require assistance devices for ambulation.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: PRE-OPERATIVE EXERCISE TRACKING

Participant baseline information will be collected from their electronic medical records.

After enrollment, participants will be provided a mobile device (Fitbit) to wear for tracking steps for 1 week prior to their scheduled surgery.

Participants will keep a log of daily steps for the 1 week they are wearing the device and receive one progress check-in call during the week.

The device and log will be turned in either on a pre-surgery clinic visit or on the day of surgery whichever comes first.

Interventions

Fitbit

Electronic activity tracker

Primary outcome measure

  • Step Tracking Rate [ Time Frame: 1 week ]
  • Diary of Steps Rate [ Time Frame: 1 week ]
  • Return Rate [ Time Frame: 1 week ]
  • Data Retrieval Rate [ Time Frame: 1 week ]

Central Contacts and Locations

Central contacts

Michael T Jaklitsch, MD

617-732- 6988mjaklitsch@bwh.harvard.edu

Anupama Singh, MD

781-492-5807asingh54@bwh.harvard.edu

Locations

Brigham and Women's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

Michael Jaklitsch, MD

617-732- 6988mjaklitsch@bwh.harvard.edu

Principal Investigator:

Michael Jaklitsch, MD

Dana-Farber Cancer Institute

Recruiting

Boston, Massachusetts, United States, 02215

Contacts

Michael T Jaklitsch, MD

617-732- 6988mjaklitsch@bwh.harvard.edu

Principal Investigator:

Michael T Jaklitsch, MD

More Information

Sponsor

Dana-Farber Cancer Institute

Last update posted

Apr 13, 2025

Last verified

Apr, 2025

Keywords

  • Thoracic Diseases
  • Lung Resection
  • Perioperative activity
  • Pedometer tracker

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2025-04-13.